Skip to main content
. 2020 Sep 25;10:1767. doi: 10.3389/fonc.2020.01767

Figure 2.

Figure 2

(A) Representative, contrast-adjusted DIGE image of depleted serum. Numbers indicate spots higher abundant in ovarian vs. peripheral blood from early stage ovarian cancer patients and ovarian blood from patients with benign ovarian lesions. (B) Boxplots of spot abundance across the analyzed DIGE gels. Samples: CO, Cancer ovarian serum; CP, Cancer peripheral serum; and BO, Benign ovarian serum. All p-values between CO vs. CP and CO vs. BO < 0.05. JUP was identified in all spots by mass spectrometry (see Table S3).